Debrisoft can save you money.
Brackin (2018) compared Debrisoft to standard of care methods for debridement, analyzing their clinical and cost effectiveness. Wound size reduction, necrotic tissue, number of dressing changes during the trial period and supply and nursing costs were documented and evaluated.
Suprasorb G was applied as wound dressing to provide a moist wound healing environment.
Results show impressive improvement and cost reduction when using Debrisoft for cleansing and debridement.

Results
Table 1. Collagenase
Initial Size (cm) | Size reduction | Necrotic Tissue Reduction |
3.0 x 4.8 | 39% | 15% |
9.0 x 6.2 | +4% | 0% |
3.3 x 3.0 | 27% | 20% |
3.5 x 2.5 | 16% | 50% |
6.2 x 2.0 | 4% | 28% |
Supply/Nursing cost: $1926 | Average Size Reduction: 21% | Dressing changes in trial period: SEVEN |
Table 2. Medical honey
Initial Size (cm) | Size reduction | Necrotic Tissue Reduction |
4.6 x 3.0 | 3% | 28% |
2.5 x 2.5 | 52% | 52% |
3.0 x 3.0 | 17% | 48% |
11.0 x 4.5 | 20% | 100% (2.5cm2) |
5.0 x 3.0 | 0% | 20% |
Supply/Nursing cost: $448 | Average Size Reduction: 18% | Dressing changes in trial period: THREE |
Table 3. Dynamic gel with MFD
Initial Size (cm) | Size reduction | Necrotic Tissue Reduction |
3.5 x 2.0 | 83% | 66% |
3.7 x 1.0 | 100% | 100% (1.85cm2) |
3.0 x 3.0 | 79% | 100% (4.5cm2) |
22 x 5.0 | 43% | N/A |
2.0 x 1.5 | 82% | 100% (1.5cm2) |
Supply/Nursing cost: $181 | Average Size Reduction: 77% | Dressing changes in trial period: ONE |